Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer-Reference-Cited by-同舟云学术

Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer

Published:2015-08-24 Issue:19 Volume:121 Page:3444-3451
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Watkins Jack L.¹,Thaker Premal H.²,Nick Alpa M.³,Ramondetta Lois M.³,Kumar Sanjeev⁴,Urbauer Diana L.⁵,Matsuo Koji⁶,Squires Kathryn C.²,Coleman Robert L.³,Lutgendorf Susan K.⁷⁸⁹,Ramirez Pedro T.³,Sood Anil K.³¹⁰¹¹

Affiliation:

1. Department of Clinical Effectiveness; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology; Washington University School of Medicine; St. Louis Missouri

3. Department of Gynecologic Oncology and Reproductive Medicine; The University of Texas MD Anderson Cancer Center; Houston Texas

4. Division of Obstetrics and Gynecology; The Mayo Clinic; Rochester Minnesota

5. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston Texas

6. Gynecologic Oncology Center, Department of Obstetrics and Gynecology; Mercy Medical Center; Baltimore Maryland

7. Department of Psychology; University of Iowa; Iowa City Iowa

8. Department of Obstetrics and Gynecology; University of Iowa; Iowa City Iowa

9. Department of Urology; University of Iowa; Iowa City Iowa

10. Department of Cancer Biology; The University of Texas MD Anderson Cancer Center; Houston Texas

11. Center for RNA Interference and Non-Coding RNA Program, Department of Experimental Therapeutics; The University of Texas MD Anderson Cancer Center; Houston Texas

Funder

National Institutes of Health

U.S. Department of Defense

Gynecologic Cancer Foundation-St. Louis Ovarian Cancer Awareness grant

Ovarian Cancer Research Fund Inc.

The Gilder Foundation

The RGK Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Link